Enlivex Receives First FDA Approval For Phase2b Trial Of Allocetra For Age-Related Osteoarthritis - Enlivex (NASDAQ:ENLV)
Published on March 23, 2026.
The first time the world's largest company has received approval for its drug, Allocetra, has been successfully marketed as a treatment for age-related issues. The drug is also being investigated for potential violations of the law. The company is seeking to establish a permanent basis in the future of this treatment.
Related Articles
Palantir Technologies shares are trading higher after reports suggesting that its Maven system will be listed by the Pentagon as a program of record, which may bolster future funding and deals for the AI weapons-targeting tool. - Palantir Technologies (NASDAQ:PLTR)
Palantir Technologies shares rose slightly after reports suggested that its Maven system would be listed as a potential government program, boosting investor confidence.
JP Morgan Maintains Neutral on Extra Space Storage, Raises Price Target to $144 - Extra Space Storage (NYSE:EXR)
JP Morgan maintains neutral status on Extra Space Storage, raising hopes for a potential $10,000 boost due to recent high-profile deaths, despite concerns over safety and integration.
President Trump Says Strait Of Hormuz Will Be Opened Very Soon If There's A Deal - State Street SPDR S&P 500 ETF Trust (ARCA:SPY), United States Oil Fund (ARCA:USO)
President Trump announced plans to open the Strait of Hormuz to the public soon, prompting excitement from both sides of the Atlantic;.